Dysregulation of the PPARα signaling can lead to the generation of markers which are known to be precursor to early nonalcoholic fatty liver disease (NAFLD)-like symptoms13,14. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.